Search clinical trials for: sitagliptin and acarbose
Total 270825 results
-
The Catholic University of KoreaBayerCompletedType 2 Diabetes MellitusKorea, Republic of
-
Wuhan General Hospital of Guangzhou Military CommandCompletedCoronary Artery Disease | Newly Diagnosed Type 2 DiabetesChina
-
Nanjing First Hospital, Nanjing Medical UniversityCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
AstraZenecaCompletedHeart Failure | Type 2 Diabetes MellitusUnited States, Thailand, Korea, Republic of, Russian Federation, Ukraine, Hungary, Bulgaria, Chile, Canada, Romania
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, South Africa, Norway, Argentina, Belgium, Denmark, Sweden, France, Italy
-
AstraZenecaCompletedType 2 DiabetesUnited States, Hungary, Mexico, South Africa, Romania, Poland
-
Alexandria UniversityRecruiting
-
Peking UniversityUnknownObesity | Diabetes Mellitus, Type 2China
-
Chinese PLA General HospitalUnknownAtherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
-
University of Sao Paulo General HospitalInCor Heart InstituteCompletedPlatelet Aggregation During Acute Myocardial InfarctionBrazil
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
EMSCompletedType 2 Diabetes MellitusBrazil
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2United States, Puerto Rico, Germany, United Kingdom, Austria
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
Peking Union Medical College HospitalChinese Academy of SciencesUnknown
-
BayerCompletedDiabetes Mellitus, Type 2Germany
-
Merck Sharp & Dohme LLCCompleted
-
BayerCompleted
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Lin LiaoUnknownType 2 Diabetes MellitusChina
-
Guiyang Medical UniversityNot yet recruitingHead and Neck Squamous CarcinomaChina
-
Astellas Pharma IncCompleted
-
The Cleveland ClinicCompleted
-
Radboud University Medical CenterCompletedType 2 Diabetes | Endothelial DysfunctionNetherlands
-
Lund UniversityCompleted
-
The University of Texas Health Science Center at...Completed
-
GWT-TUD GmbHTechnische Universität Dresden; University of Regensburg; Diakonissen Krankenhaus...CompletedType 2 Diabetes Mellitus | Subclinical InflammationGermany
-
Korea University Anam HospitalAstraZenecaUnknownDiabetes Mellitus, Type IIKorea, Republic of
-
GWT-TUD GmbHCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Technische Universität DresdenCompleted
-
Aichi Gakuin UniversityUnknownCoronary Artery Disease | Diabetes Mellitus | Impaired Glucose ToleranceJapan
-
Zealand University HospitalCompletedObesity | Hypoglycemia | Surgery
-
AgelessRxCompletedTolerance | Side Effect | Glucose ResponseUnited States
-
BayerCompletedDiabetes MellitusRussian Federation, India, Korea, Republic of, Indonesia, Malaysia, Philippines, Singapore, Thailand, China, Hong Kong, Pakistan, Vietnam, Algeria, Moldova, Republic of, Bosnia and Herzegovina, Cambodia
-
Karolinska InstitutetBayer; The Swedish Research CouncilCompleted
-
BayerCompletedDiabetes MellitusKorea, Republic of
-
BayerCompleted
-
BayerCompleted
-
University of Alabama at BirminghamNot yet recruitingKidney CancerUnited States
-
BayerCompleted
-
Merck Sharp & Dohme LLCCompleted
-
BayerCompleted
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
He XiaUnknown
-
BayerCompleted
-
Inje UniversitySanofiCompletedDiabetes Mellitus | Type 2 Diabetes MellitusKorea, Republic of